Besides, patients with NAFLD-HCC were older, more often female, and had better liver function as evidenced by higher albumin levels, lower international normalised ratio (INR) and model for end-stage liver disease (MELD) scores, whereas higher platelet counts suggested less severe portal hypertension (Table 1). The gene discussed is ALB; the disease is metabolic dysfunction-associated steatotic liver disease.